Polycythemia vera causes: Difference between revisions
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Polycythemia vera}} | {{Polycythemia vera}} | ||
{{CMG}}{{AE}}{{MJK}} {{shyam}} | {{CMG}}{{AE}} {{IO}} {{MJK}} {{shyam}} | ||
==Overview== | ==Overview== | ||
Polycythemia vera is caused by a mutation in the [[Janus kinase|JAK2]] gene (V617F mutation). This mutation occurs in more than 98% of cases of polycythemia vera. The [[Janus kinase|JAK2]] exon 12 [[mutation]] occurs in a small proportion of patients. There are no other causes of this disease. | Polycythemia vera is caused by a mutation in the [[Janus kinase|JAK2]] gene (V617F mutation). This mutation occurs in more than 98% of cases of polycythemia vera. The [[Janus kinase|JAK2]] exon 12 [[mutation]] occurs in a small proportion of patients. There are no other causes of this disease. |
Latest revision as of 02:57, 14 September 2019
Polycythemia vera Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Polycythemia vera causes On the Web |
American Roentgen Ray Society Images of Polycythemia vera causes |
Risk calculators and risk factors for Polycythemia vera causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Ifeoma Odukwe, M.D. [2] Mohamad Alkateb, MBBCh [3] Shyam Patel [4]
Overview
Polycythemia vera is caused by a mutation in the JAK2 gene (V617F mutation). This mutation occurs in more than 98% of cases of polycythemia vera. The JAK2 exon 12 mutation occurs in a small proportion of patients. There are no other causes of this disease.
Causes
Common Causes
Common causes of polycythemia vera may include:[1]
- JAK2 V617F gene mutation. This mutation is found in more than 95% of cases of polycythemia vera. It is a point mutation in which valine is replaced by phenylalanine at the 617th position of the gene. The mutation occurs in exon 14 of the JAK2 gene.
Less Common Causes
Less common causes of polycythemia vera include:[1]
- JAK2 exon 12 gene mutation
- LNK (SH2B3) gene mutation (inhibitor of JAK-STAT signaling pathway)
- TET2 gene mutation
- SF3B1 gene mutation (involved in RNA splicing)
- DNMT3A gene mutation (involved in epigenetic regulation)
- ASXL1 gene mutation
Genetic Causes
- Polycythemia vera is caused by a mutation in various genes. They include:[1]
- JAK2
- TET2
- SF3B1
- DNMT3A
- ASXL1
Causes by Organ System
Cardiovascular | No underlying causes |
Chemical/Poisoning | No underlying causes |
Dental | No underlying causes |
Dermatologic | No underlying causes |
Drug Side Effect | No underlying causes |
Ear Nose Throat | No underlying causes |
Endocrine | No underlying causes |
Environmental | No underlying causes |
Gastroenterologic | No underlying causes |
Genetic | JAK2 V617F point mutation, JAK2 exon 12, TET2, SF3B1, DNMT3A, ASXL1 |
Hematologic | No underlying causes |
Iatrogenic | No underlying causes |
Infectious Disease | No underlying causes |
Musculoskeletal/Orthopedic | No underlying causes |
Neurologic | No underlying causes |
Nutritional/Metabolic | No underlying causes |
Obstetric/Gynecologic | No underlying causes |
Oncologic | No underlying causes |
Ophthalmologic | No underlying causes |
Overdose/Toxicity | No underlying causes |
Psychiatric | No underlying causes |
Pulmonary | No underlying causes |
Renal/Electrolyte | No underlying causes |
Rheumatology/Immunology/Allergy | No underlying causes |
Sexual | No underlying causes |
Trauma | No underlying causes |
Urologic | No underlying causes |
Miscellaneous | No underlying causes |
Causes in Alphabetical Order
List the causes of the disease in alphabetical order:
- ASXL1 gene mutation
- DNMT3A gene mutation
- JAK2 gene mutation
- SF3B1 gene mutation
- TET2 gene mutation
References
- ↑ 1.0 1.1 1.2 Stein BL, Oh ST, Berenzon D, Hobbs GS, Kremyanskaya M, Rampal RK, Abboud CN, Adler K, Heaney ML, Jabbour EJ, Komrokji RS, Moliterno AR, Ritchie EK, Rice L, Mascarenhas J, Hoffman R (November 2015). "Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F". J. Clin. Oncol. 33 (33): 3953–60. doi:10.1200/JCO.2015.61.6474. PMC 4979103. PMID 26324368.